Other Updated 2026-01-13

Teva Octreotide for injectable suspension recalled due to potential drug quality issues

See all recalls from Teva →
Share: Facebook X / Twitter WhatsApp

Recalled Product

All strengths of Teva Octreotide for Injectable Suspension Kit (DIN 02503751, 02503778 and 0253786) with the lot numbers noted below.


✅ What Should You Do?

  1. ⚠️ Stop using this product until you have checked the recall details below.
  2. If you have an affected product, do not use it.
  3. 💰 Check if you are eligible for a refund or free replacement from the retailer or manufacturer.
  4. 📋 Report a product safety incident to Health Canada
Looking for a safe alternative? Search Amazon Canada for All strengths of Teva →

Hazard / Issue

Product quality

Issued by

Communications and Public Affairs Branch

⚠️ What You Should Do

If you have an affected product, do not use it. Speak to your health care professional immediately to obtain an alternative or replacement product. If you are unsure whether your product is affected, check with your pharmacy. Seek medical attention if you have used this product and are experiencing symptoms of infection, or other unexpected symptoms or side effects.Return affected product(s) to the pharmacy where it was purchased for proper disposal.Consult a health care professional if you have used the affected product and have health concerns.Contact Teva Canada Limited by calling toll-free at 1-800-268-4127, option 3, or by email at druginfo@tevacanada.com, if you have questions about this recall.Report any health product-related side effects or complaints to Health Canada.
View official government recall